Fonte: European Journal of Clinical Pharmacology. Unidades: EERP, FMRP
Assuntos: ENDOTÉLIO VASCULAR, HIPERTENSÃO, POLIMORFISMO, VASODILATAÇÃO
ABNT
OLIVEIRA-PAULA, G. H. e LACCHINI, Riccardo e TANUS-SANTOS, José Eduardo. In reply to: Enalapril and the VEGFA gene [Carta]: personalized medicine in hypertension therapy. European Journal of Clinical Pharmacology. Heidelberg: Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s00228-015-1985-x. Acesso em: 02 nov. 2024. , 2016APA
Oliveira-Paula, G. H., Lacchini, R., & Tanus-Santos, J. E. (2016). In reply to: Enalapril and the VEGFA gene [Carta]: personalized medicine in hypertension therapy. European Journal of Clinical Pharmacology. Heidelberg: Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo. doi:10.1007/s00228-015-1985-xNLM
Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. In reply to: Enalapril and the VEGFA gene [Carta]: personalized medicine in hypertension therapy [Internet]. European Journal of Clinical Pharmacology. 2016 ; 72( 1): 127-128.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1007/s00228-015-1985-xVancouver
Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. In reply to: Enalapril and the VEGFA gene [Carta]: personalized medicine in hypertension therapy [Internet]. European Journal of Clinical Pharmacology. 2016 ; 72( 1): 127-128.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1007/s00228-015-1985-x